Page 22 - Journal of Structural Heart Disease Volume 2, Issue 5

223
Original Research Article
associated conditions and the impact of physiological size. J Am Coll Cardiol. 2001;38:613-623. DOI: 10.1016/S0735- 1097(01)01427-9
9. Wahl A, Praz F, Tai T, Findling O, Walpoth N, Nedeltchev K, et al. Improvement of mi- graine headaches after percutaneous clo- sure of patent foramen ovale for second- ary prevention of paradoxical embolism. Heart. 2010;96:967-973. DOI: 10.1136/ hrt.2009.181156
10. Godart F, Rey C, Prat A, Vincentelli A, Chmaït A, Francart C, et al. Atrial right-to-left shunt- ing causing severe hypoxaemia despite normal right-sided pressures. Report of 11 consecutive cases corrected by percutane- ous closure. Eur Heart J. 2000;21:483-489. DOI: 10.1053/euhj.1999.1944
11. Amin Z. Echocardiographic predictors of cardiac erosion after amplatzer septal occluder placement. Catheter Cardio- vasc Interv. 2014;83:84-92. DOI: 10.1002/ ccd.25175
12. Wagdi P. Incidence and predictors of atrial brillation following transcatheter closure of interatrial septal communications using contemporary devices. Clin Res Cardiol. 2010;99:507-510. DOI: 10.1007/s00392- 010-0149-3
13. Goel SS, Olcay A, Tuzcu EM, Krasuski RA, Kapadia SR. Embolization of patent foramen ovale closure devices: incidence, role of im- aging in identi cation, potential causes, and management. Texas Hear Inst J. 2013;40:439- 444. DOI: 10.1016/j.jcin.2011.01.009
14. AGA Medical Corporation. Multifenestrated Septal Occluder – “Cribriform.” Instructions for Use. St. Paul: AGA Medical Corporation. 2011:1-10.
15. Alibegovic J, Bonvini R, Sigwart U, Dorsaz P,
16.
17.
18.
19.
Camenzind E, Verin V. The role of the sizing balloon in selection of the patent foramen ovale closure device size. Exp Clin Cardiol. 2008;13:42-46. PMID: 18650972
Bonvini RF, Sigwart U, Verin V. Interatrial septum rupture during balloon measure- ment of a patent foramen ovale in a young patient presenting cryptogenic stroke. Catheter Cardiovasc Interv. 2007;69:274- 276. DOI: 10.1002/ccd.20969
Inglessis I, Elmariah S, Rengifo-Moreno PA, Margey R, O’Callaghan C, Cruz-Gon- zalez I, et al. Long-term experience and outcomes with transcatheter closure of patent foramen ovale. JACC Cardiovasc Interv. 2013;6:1176-1183. DOI: 10.1016/j. jcin.2013.06.013
Bissessor N, Wong AW, Hourigan LA, Jayasinghe RS, Scalia GS, Burstow DJ, et al. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices. Cardiovasc Revasc Med. 2011;12:164-169. DOI: 10.1016/j.car- rev.2010.06.001
Wahl A, Tai T, Praz F, Schwerzmann M, Seiler C, Nedeltchev K, et al. Late results after percutaneous closure of patent foramen ovale for secondary prevention of para- doxical embolism using the amplatzer PFO occluder without intraprocedural echoc- ardiography: e ect of device size. JACC Cardiovasc Interv. 2009;2:116-123. DOI: 10.1016/j.jcin.2008.09.013
LATIONAHA.111.030494
21. Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyheh I, et al. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2013;6:1316-1323. DOI: 10.1016/j.jcin.2013.08.001
22. Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonalad LA, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368:1092-1100. DOI: 10.1056/ NEJMoa1301440
23. Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, et al. Percuta- neous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368:1083-1091. DOI: 10.1056/NE- JMoa1211716
24. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366:991-999. DOI: 10.1056/NE- JMoa1009639
20.Wahl A, Jüni P, Mono ML, Kalesan B, Praz F, Geister L, et al. Long-term pro- pensity score-matched comparison of percutaneous closure of patent fora- men ovale with medical treatment after paradoxical embolism. Circulation. 2012;125:803-812. DOI: 10.1161/CIRCU-
Venturini, J.M. et al.
Device Sizing for Percutaneous PFO Closure
Cite this article as: Venturini JM, Retzer EM, Estrada JR, Mediratta A, Friant J, Nathan S, Paul JD, Blair J, Lang RM, Shah AP. A Practical Scoring System to Select Optimally Sized Devices for Percutaneous Patent Foramen Ovale Closure. Journal of Structural Heart Disease. 2016;2(5):217-223. DOI: http:// dx.doi.org/10.12945/j.jshd.2016.009.15